BioLight Life Sciences Ltd. (TLV:BOLT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
290.20
-10.00 (-3.33%)
Sep 8, 2026, 5:24 PM IDT

BioLight Life Sciences Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
263225243053
Market Cap Growth
4.61%25.69%4.99%-19.99%-42.70%53.43%
Enterprise Value
14111312512
Last Close Price
2.903.525.445.206.6111.54

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----137.74
PS Ratio
--115.64204.41478.5417539.14
PB Ratio
0.840.810.820.800.560.86
P/TBV Ratio
0.960.940.970.830.570.87

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--58.93104.0286.874057.47

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.020.020.000.010.01
Net Debt / Equity Ratio
-0.48-0.55-0.42-0.28-0.32-0.54
Net Debt / EBITDA Ratio
1.001.431.280.851.763.30
Net Debt / FCF Ratio
1.272.001.170.781.793.13
Asset Turnover
--0.010.000.000
Quick Ratio
7.0111.216.523.736.9515.25
Current Ratio
7.0112.196.943.917.1115.38
Return on Equity (ROE)
-59.85%-48.42%-27.60%-65.45%-15.09%-0.56%
Return on Assets (ROA)
-30.82%-24.84%-18.71%-14.72%-10.65%-10.27%
Return on Invested Capital (ROIC)
-94.72%-86.12%-51.07%-36.51%-31.89%-55.70%
Return on Capital Employed (ROCE)
-46.60%-37.60%-31.60%-34.20%-18.90%-17.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.56%-36.84%-28.20%-107.88%-26.03%0.73%
FCF Yield
-45.26%-34.12%-43.52%-45.57%-31.75%-20.20%
Buyback Yield / Dilution
-74.07%-27.27%-0.29%-1.70%0.41%-0.94%